Technology News and Research

RSS

OCLS' partnership with V&M Industries to market Microcyn-based skin and wound care products

Oculus Innovative Sciences, Inc., a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn Technology platform, which is intended to treat infections in chronic and acute wounds, announced today it has entered into a new strategic partnership with V&M Industries, Inc. for non-exclusive rights to market Microcyn-based skin and wound care over-the-counter products in the United States and Canada while providing Oculus with a significant percentage of those revenues.

16 Sep 2009

FindPharma.com website for pharma professionals

Advanstar Communications announced today that it has launched FindPharma.com, a digital vertical search destination that will enable pharma professionals to find and filter relevant industry information, high quality suppliers and career assistance.

16 Sep 2009

i365’s EVault Plug-n-Protect chosen to back up critical patient and business data of Medical Business Service

i365, Inc., A Seagate Company (NASDAQ: STX), today announced that Medical Business Service, Inc. has moved to i365’s EVault Plug-n-Protect appliance for its complete data protection and recovery capabilities. Headquartered in Coral Gables, Florida, and the largest privately owned patient billing services company for hospital-based physicians, MBS required a reliable, efficient data protection solution that would allow it to back up critical patient and business data across the company’s thirteen branches.

16 Sep 2009

KemPharm announces nomination of its second pipeline candidate

KemPharm, Inc. today announced the nomination of its second pipeline candidate, KP201, based on its proprietary ligand activated therapy (LAT) platform. KP201 is a new chemical entity (NCE) for the treatment of pain with the possibility of reduced abuse potential. KP201 joins lead candidate KP106, which is a novel prodrug candidate in development for ADHD.

16 Sep 2009

Phytel's Proactive Patient Outreach solution to be deployed at the Mankato Clinic

Phytel, the industry leader in automated, physician-led health improvement, announced today that the Mankato Clinic, one of the largest physician-owned multispecialty groups in Minnesota, has agreed to deploy its Proactive Patient Outreach solution. The nearly century-old Mankato Clinic, which includes 110 providers in nine locations, selected Phytel to help reduce its no-show rate and to increase the provision of needed services to its patients.

16 Sep 2009

Children's Hospital enrolls patients for ExCell clinical study

Children's Hospital of Colorado and the Gamida Cell-Teva Joint Venture announced today that Children's Hospital is enrolling patients for the ExCell study. Children's Hospital is the 24th in a series of cord blood transplant sites worldwide, five of which are children's centers, participating in the study in the U.S., Spain, Italy, Hungary and Israel.

16 Sep 2009

Premion commences cancer treatment with Varian's RapidArc radiotherapy technology

Cancer patients in Australia have gained access to advanced RapidArc(R) radiotherapy treatments from Varian Medical Systems (NYSE: VAR) with its introduction by the leading radiation oncology provider in Queensland. Premion, which operates five cancer centers in Queensland, has treated more than a dozen prostate cancer patients to date with this fast, precise and efficient technique at its Chermside treatment center in Brisbane.

16 Sep 2009

Inovio’s novel platform for developing DNA based vaccines to be discussed at EmTech

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that Dr. J. Joseph Kim, CEO, has been invited to present at EmTech, the Emerging Technologies Conference hosted by MIT and produced by MIT’s Technology Review magazine. The conference will take place September 22nd - 24th on the MIT campus in Cambridge, MA.

16 Sep 2009

CEL-SCI to commence its LEAPS-H1N1 clinical trial following FDA approval

CEL-SCI Corporation (NYSE Amex: CVM), a developer of vaccines and therapeutics for the prevention and treatment of infectious diseases and a late-stage oncology company, announced today that the U.S. Food and Drug Administration (FDA) has indicated that the Company can proceed with its first clinical trial to evaluate the effect of its investigational LEAPS-H1N1 treatment on the white blood cells of hospitalized H1N1 patients.

16 Sep 2009

Winner of LA's Best Award 2009

Los Angeles dentist, Dr. Sam Muslin, DDS, MAGD, has been awarded LA's Best Award (tm) 2009 for his leading edge, high quality dentistry.

16 Sep 2009

Perceptive Informatics utilizes Optasia's KneeAnalyzer software

Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation, today announced that it has enhanced its capabilities to provide medical imaging measurements for osteoarthritis clinical trials through an alliance with Optasia Medical, Inc.

From Parexel 16 Sep 2009

Savient updates on its Biologics License Application with the FDA for KRYSTEXXA

Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) announced that on September 14, 2009, the Company completed a Type A meeting with the U.S. Food and Drug Administration (FDA) to discuss the Complete Response Letter (CRL) received by Savient on July 31, 2009 regarding the Company's Biologics License Application (BLA) for KRYSTEXXA(TM) (pegloticase) as a treatment for chronic gout in patients refractory to conventional therapy.

16 Sep 2009

Phase Forward advances its clinical trial and drug safety data management capabilities

For many large pharmaceutical and medical device firms, the task of capturing and managing volumes of clinical trial and drug safety data is often outsourced to experts like Phase Forward.

16 Sep 2009

BioClinica obtains Tourtellotte Solutions

BioClinica, Inc., a global provider of clinical trial services, today announced that it has acquired privately-held Tourtellotte Solutions, Inc. (Tourtellotte), a leader in software and services for the bio-pharmaceutical industry.

From Clario 16 Sep 2009

Next Generation Advanced Image Processing for Toshiba Infinix-i product line

Improving the ability to provide premium patient care during interventional procedures, Toshiba America Medical Systems, Inc. is expanding the availability of Next Generation Advanced Image Processing (AIP) to more systems in the Toshiba InfinixTM-i product line.

16 Sep 2009

Global medical device manufacturer procures Sono-Tek's MediCoat stent coating systems worth $400,000

Sono-Tek Corporation (OTC Bulletin Board: SOTK) announced today the sale of a series of its MediCoat DES 2000 stent coating systems to a leading global medical device manufacturer. The sale is Sono-Tek's largest ever sales transaction to the medical device industry, valued at approximately $400,000.

16 Sep 2009

Software for screening adulterated raw milk

FOSS has extended the availability of software functionality that helps to spot adulterated raw milk. The software allows MilkoScan(TM) analysers based on Fourier Transform Infrared (FTIR) technology to be programmed to give a warning of possible abnormalities in raw milk samples. MilkoScan instruments are already used around the world to check milk for payment and quality assurance purposes.

16 Sep 2009

New mobile phone software helps remote analysis of data and map findings

New mobile phone software will help epidemiologists and ecologists working in the field to analyse their data remotely and map findings across the world, without having to return to the lab, according to research published in PLoS One today. The authors of the study, from Imperial College London, say the software will also enable members of the public to act as 'citizen scientists' and help collect data for community projects.

16 Sep 2009

RXi Pharmaceuticals to present in vivo data of rxRNA compounds

RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that it will be presenting new in vivo data on its self-delivering rxRNA compounds at a number of upcoming scientific conferences, detailed below.

16 Sep 2009

Toll-like receptors that activate immune cells being developed as alternative cure to cancer

A Toll-like receptor (TLR) agonist, called imiquimod, which activates dendritic cells, is in clinical use as a topical application for basal cell carcinoma. In addition, a number of TLR agonists have been evaluated in clinical trials as an adjuvant for cancer vaccines.

16 Sep 2009

Technology News and Research

OCLS' partnership with V&M Industries to market Microcyn-based skin and wound care products

FindPharma.com website for pharma professionals

i365’s EVault Plug-n-Protect chosen to back up critical patient and business data of Medical Business Service

KemPharm announces nomination of its second pipeline candidate

Phytel's Proactive Patient Outreach solution to be deployed at the Mankato Clinic

Children's Hospital enrolls patients for ExCell clinical study

Premion commences cancer treatment with Varian's RapidArc radiotherapy technology

Inovio’s novel platform for developing DNA based vaccines to be discussed at EmTech

CEL-SCI to commence its LEAPS-H1N1 clinical trial following FDA approval

Winner of LA's Best Award 2009

Perceptive Informatics utilizes Optasia's KneeAnalyzer software

Savient updates on its Biologics License Application with the FDA for KRYSTEXXA

Phase Forward advances its clinical trial and drug safety data management capabilities

BioClinica obtains Tourtellotte Solutions

Next Generation Advanced Image Processing for Toshiba Infinix-i product line

Global medical device manufacturer procures Sono-Tek's MediCoat stent coating systems worth $400,000

Software for screening adulterated raw milk

New mobile phone software helps remote analysis of data and map findings

RXi Pharmaceuticals to present in vivo data of rxRNA compounds

Toll-like receptors that activate immune cells being developed as alternative cure to cancer

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News